Relational Graph Convolutional Networks for Glioblastoma Biomarker Discovery via ceRNA and Copy Number Variation Analysis
Glioblastoma (GBM) is a highly aggressive brain tumor with an extremely poor 5-year survival rate of 6.9%, largely attributable to the lack of reliable biomarkers. While competing endogenous RNA (ceRNA) and copy number variation (CNV) analyses offer unique biomarker identification potential, current approaches neglect the integration of multiple regulatory mechanisms for biomarker detection. To…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
